SCHEMBL14729150

SCHEMBL14729150

CC(C)c1c2c(c(C(C)C)c3ccccc13)-c1ccc3c4ccc5c6c(-c7ccc(F)cc7)c7c(cc8c9ccccc9c9cccc7c98)c(-c7ccc(F)cc7)c6c6ccc(c7ccc-2c1c73)c4c65

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CDC25A P30304 1/20 0.30
▸ CDC25C P30307 1/20 0.30
▸ GCGR P47871 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14729147 0.86 CYP1A2 (0.33) —
SCHEMBL11954578 0.78 PTGS2 (0.31) —
SCHEMBL14729149 0.74 — —
SCHEMBL22328875 0.73 DHODH (0.32) —
SCHEMBL25006638 0.73 FABP4 (0.33) —
SCHEMBL14729148 0.72 — —
SCHEMBL15385295 0.70 IMPDH2 (0.35) —
SCHEMBL23805916 0.70 ALDH1A1 (0.40) GCGR
SCHEMBL10015397 0.70 CYP1A2 (0.35) —
SCHEMBL21705051 0.70 GPR84 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8900727-B2 Condensed polycyclic compound, organic light-emitting device having the same, display device, image information processing device, lighting device, image formation device, and exposure light source CANON KABUSHIKI KAISHA (JP) 2014-12-02 — — US disclosed
US-8900727-B2 Condensed polycyclic compound, organic light-emitting device having the same, display device, image information processing device, lighting device, image formation device, and exposure light source CANON KABUSHIKI KAISHA (JP) 2014-12-02 — — US disclosed
US-20130050561-A1 NOVEL CONDENSED POLYCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME, DISPLAY DEVICE, IMAGE INFORMATION PROCESSING DEVICE, LIGHTING DEVICE, IMAGE FORMATION DEVICE, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2013-02-28 — — US disclosed
US-20130050561-A1 NOVEL CONDENSED POLYCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME, DISPLAY DEVICE, IMAGE INFORMATION PROCESSING DEVICE, LIGHTING DEVICE, IMAGE FORMATION DEVICE, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2013-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130050561-A1 NOVEL CONDENSED POLYCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME, DISPLAY DEVICE, IMAGE INFORMATION PROCESSING DEVICE, LIGHTING DEVICE, IMAGE FORMATION DEVICE, AND EXPOSURE LIGHT SOURCE CCND2, CCNE2, C1R CDC25A 1467/4885CDC25C 2348/4885GCGR 1469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback